Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16298129rdf:typepubmed:Citationlld:pubmed
pubmed-article:16298129lifeskim:mentionsumls-concept:C0038172lld:lifeskim
pubmed-article:16298129lifeskim:mentionsumls-concept:C0012892lld:lifeskim
pubmed-article:16298129lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:16298129lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:16298129lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:16298129pubmed:issue4lld:pubmed
pubmed-article:16298129pubmed:dateCreated2006-1-9lld:pubmed
pubmed-article:16298129pubmed:abstractTextThe preparation and biological evaluation of 5-substituted-6-hydroxy-2-(anilino)pyrimidinones as a new class of DNA polymerase IIIC inhibitors, required for the replication of chromosomal DNA in Gram-positive bacteria, are described. These new dGTP competitive inhibitors displayed good levels of in vitro inhibition and antibacterial activity against Staphylococcus aureus. A new class of dATP competitive inhibitors, 6-substituted-2-amino-5-alkyl-pyrimidin-4-ones, whose antibacterial activity was unaffected by serum, were identified.lld:pubmed
pubmed-article:16298129pubmed:languageenglld:pubmed
pubmed-article:16298129pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16298129pubmed:citationSubsetIMlld:pubmed
pubmed-article:16298129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16298129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16298129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16298129pubmed:statusMEDLINElld:pubmed
pubmed-article:16298129pubmed:monthFeblld:pubmed
pubmed-article:16298129pubmed:issn0960-894Xlld:pubmed
pubmed-article:16298129pubmed:authorpubmed-author:PoirierHugoHlld:pubmed
pubmed-article:16298129pubmed:authorpubmed-author:ReddyRangaRlld:pubmed
pubmed-article:16298129pubmed:authorpubmed-author:FarAdel...lld:pubmed
pubmed-article:16298129pubmed:authorpubmed-author:DelormeDaniel...lld:pubmed
pubmed-article:16298129pubmed:authorpubmed-author:McKayGeoffrey...lld:pubmed
pubmed-article:16298129pubmed:authorpubmed-author:DietrichEvely...lld:pubmed
pubmed-article:16298129pubmed:authorpubmed-author:RoseYannickYlld:pubmed
pubmed-article:16298129pubmed:authorpubmed-author:CiblatStéphan...lld:pubmed
pubmed-article:16298129pubmed:authorpubmed-author:BelleyAdam...lld:pubmed
pubmed-article:16298129pubmed:authorpubmed-author:LehouxDarioDlld:pubmed
pubmed-article:16298129pubmed:issnTypePrintlld:pubmed
pubmed-article:16298129pubmed:day15lld:pubmed
pubmed-article:16298129pubmed:volume16lld:pubmed
pubmed-article:16298129pubmed:ownerNLMlld:pubmed
pubmed-article:16298129pubmed:authorsCompleteYlld:pubmed
pubmed-article:16298129pubmed:pagination891-6lld:pubmed
pubmed-article:16298129pubmed:meshHeadingpubmed-meshheading:16298129...lld:pubmed
pubmed-article:16298129pubmed:meshHeadingpubmed-meshheading:16298129...lld:pubmed
pubmed-article:16298129pubmed:meshHeadingpubmed-meshheading:16298129...lld:pubmed
pubmed-article:16298129pubmed:meshHeadingpubmed-meshheading:16298129...lld:pubmed
pubmed-article:16298129pubmed:meshHeadingpubmed-meshheading:16298129...lld:pubmed
pubmed-article:16298129pubmed:meshHeadingpubmed-meshheading:16298129...lld:pubmed
pubmed-article:16298129pubmed:meshHeadingpubmed-meshheading:16298129...lld:pubmed
pubmed-article:16298129pubmed:meshHeadingpubmed-meshheading:16298129...lld:pubmed
pubmed-article:16298129pubmed:year2006lld:pubmed
pubmed-article:16298129pubmed:articleTitleNovel non-nucleobase inhibitors of Staphylococcus aureus DNA polymerase IIIC.lld:pubmed
pubmed-article:16298129pubmed:affiliationTarganta Therapeutics Inc., 7170 Frederick-Banting, 2nd Floor, Montréal, Québec, Canada H4S 2A1. yrose@targanta.comlld:pubmed
pubmed-article:16298129pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:16298129lld:chembl